---
category: news
title: "RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease"
excerpt: "(GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced a collaboration with AstraZeneca (LSE/STO/NYSE: AZN) to develop and launch precision medicine strategies for cardiovascular,"
publishedDateTime: 2020-08-21T07:00:00Z
originalUrl: "https://apnews.com/bb576a57c6cffad3a648ae0c5ea6e32d"
webUrl: "https://apnews.com/bb576a57c6cffad3a648ae0c5ea6e32d"
type: article
quality: 26
heat: 26
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "AstraZeneca teams up with Renalytix AI in chronic diseases"
    excerpt: "AstraZeneca (NYSE:AZN) collaborates with Renalytix AI (NASDAQ:RNLX)Â to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases.The first stage in the collaboration will use KidneyIntelX,"
    publishedDateTime: 2020-08-21T07:41:00Z
    webUrl: "https://seekingalpha.com/news/3607757-astrazeneca-teams-up-renalytix-ai-in-chronic-diseases"
    type: article
    provider:
      name: Seeking Alpha
      domain: seekingalpha.com
    quality: 17

secured: "zFjpVtAF6JF04lbWrgHEKo927GEALJqU7Qv9fNUv4uvUeIv18lUXemVxSTHfbbJqFLRCdTcZoPJ9CH3LTE9ZnlV9neQy7QK7kazSiB+mBnB/CPzqjDu13oqDA6l+QTYGHbt5qmEhaZm1KEiKuFjIaXagKK6C6f4EYL17YMQIfJQfTkXYuyPaYs/8jEX5NMh2Fj1keLg9KOh8/4aAT3pxOi5NLkneGRSZkD8OF69oGrIEcRuAv+lc2KqPsmbm2aommL1Yp0hiF8b1bfEydq/TzMR7/X3dO/IP4UXPbM5dTb1glVxBOoiilAVCh3IleTN8T80lRdnvarPjibaEBfFAYQ==;GyLxnvIWrXNHCBBUt3StDA=="
---

